￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Why is it recommended to use Eltrombopag (Revlan) as little as possible and why?

2026-02-01 22:25:32

Check Details
How to deal with the correct side effects of Roprostim (Huierning) when they occur

2026-02-01 22:25:32

Check Details
The efficacy and clinical evaluation of Midostaurin in patients with acute leukemia

2026-02-01 22:25:32

Check Details
The therapeutic effect and safety of cabergoline in patients with prolactinoma

2026-02-01 22:25:32

Check Details
Which drugs cannot be taken with Momelotinib at the same time and precautions

2026-02-01 22:25:32

Check Details
Difficulties in recovering kidney function and precautions after taking Bikken Pronol Tablets (Bituvi)

2026-02-01 22:25:32

Check Details
Deuterated colexitinib (decavatinib) oral dosage form instructions and storage methods

2026-02-01 22:25:32

Check Details
Whether Apremilast has been marketed in the country and related drug policy instructions

2026-02-01 22:25:32

Check Details
How long does a typical treatment course of Valganciclovir last for kidney transplant patients?

2026-02-01 22:25:32

Check Details
Effects of Osimertinib (Tagrisso) on Liver Function and Evaluation of Side Effects

2026-02-01 22:25:32

Check Details
How long does it take for the side effects of Eltrombopag (Revlan) to disappear on their own?

2026-02-01 22:25:32

Check Details
Analysis of the efficacy of Roprostim (Huierning) in different thrombocytopenic diseases

2026-02-01 22:25:32

Check Details
Category
相关知识